Drugs like Ozempic have become so popular among people seeking to lose weight that they are now in short supply for patients with diabetes who depend on the medicines.
THE WALL STREET JOURNAL
WSJ.com
More than eight in 10 adults with type 2 diabetes in the United States could benefit from a pair of drug treatments that only a small fraction of them are currently being prescribed, a new study published today in the Annals of Internal Medicine finds.
TODAY - YAHOO! NEWS
news.yahoo.com
Some diabetes patients have had to reduce Ozempic dosing or switch to alternatives
healthline
healthline.com
Ozempic is the same medication as the popular weight loss drug Wegovy, just at a lower dose.
NBC NEWS
nbcnews.com
According to the manufacturer that creates Ozempic, Novo Nordisk, intermittent supply disruptions are expected to continue through mid-March. The company cites incredible demand coupled with overall global supply constraints as the cause.
SPECTRUM NEWS
spectrumnews1.com
Unfortunately, this social media hype has increased demand for semaglutide at the same time that its supply chain has been affected, leaving many patients with diabetes who rely on semaglutide unable to procure their medication.
AMERICAN FAMILY PHYSICIAN
aafp.org
Ozempic contains an active ingredient that also suppresses a person's appetite, which has made it popular for people searching for weight loss options even though it hasn't been approved by the FDA for weight loss.
ABC7 Chicago
abc7chicago.com